Technology | June 28, 2010

New 3-D Imaging Tool Available in U.S.

June 28, 2010 – A new 3-D imaging technology is now available in the U.S. The C-InSight from Mazor Surgical Technologies Ltd. will enable medical facilities to incorporate 3-D imaging capabilities into their existing 2-D C-arms, the standard X-ray device used in operating rooms.

Though intraoperative 3-D imaging positively impacts surgical outcomes, such technologies are prohibitively expensive for most medical centers and often expose patients, surgeons and staff to high levels of radiation. Therefore, current standard of care relies on 2-D C-arms (mobile X-ray cameras), which fail to provide surgeons with the in-depth imaging they need for intraoperative revisions. C-InSight transforms these 2-D C-arms into 3-D intraoperative imaging systems at a fraction of the price, while maintaining low radiation levels.

C-InSight provides surgeons with a high-quality 3-D image, allowing them to revise their work intraoperatively, significantly reducing the need for revision surgeries and decreasing post-surgical pain, disability and extensive rehabilitation for the patient.

The pairing of a C-arm with the C-InSight attachment emits approximately one-third less radiation than the average dedicated 3-D C-arm, significantly reducing the patient's and OR staff's exposure to radiation during surgery. C-InSight will also reduce the need for post operative CT scans, further reducing radiation and additional cost and time to the patient.

For more information: www.mazorst.com

Related Content

Bilateral Artery Use Does Not Improve 10-Year CABG Outcomes
News | Cardiovascular Surgery | September 06, 2018
While it is firmly established that the use of one internal thoracic artery can improve life expectancy in coronary...
Mandatory Public Coronary Artery Bypass Grafting Reporting Associated With Better Patient Outcomes
News | Cardiovascular Surgery | April 30, 2018
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with...
Gecko Biomedical Receives CE Mark Approval for Setalum Sealant
News | Cardiovascular Surgery | September 19, 2017
Gecko Biomedical announced it has received CE Mark approval for its Setalum Sealant, allowing the company to market its...
ClearFlow Inc. Announces Positive U.S. Clinical Trial Results
News | Cardiovascular Surgery | September 08, 2017
September 8, 2017 — ClearFlow Inc.
Videos | Cardiovascular Surgery | July 19, 2017
This video educational session, provided in partnership with the American Society of Echocardiography (ASE), is title
Intensive Glycemic Control Program Produces Significant Per-Patient Cost Savings for CABG Surgery
News | Cardiovascular Surgery | May 25, 2017
A new study from Emory University observed a near-20 percent reduction in perioperative complications, a 1.2-day...
Risk of Heart Transplant Rejection Reduced by Desensitizing Patient Antibodies
News | Cardiovascular Surgery | May 23, 2017
The risk of heart transplant rejection can be reduced by desensitizing patient antibodies, according to research...
Scientists Show How Cells React to Injury From Open-Heart Surgery
News | Cardiovascular Surgery | May 04, 2017
Cedars-Sinai Heart Institute investigators have learned how cardiac muscle cells react to a certain type of injury that...
ERACS Session Highlights Need for Standardized Best Practices in Cardiac Surgery
News | Cardiovascular Surgery | May 02, 2017
The recently formed group Enhanced Recovery After Cardiac Surgery (ERACS) hosted an organizing session in Boston on...
ClearFlow Receives Frost & Sullivan New Product Innovation Award for PleuraFlow Technology
News | Cardiovascular Surgery | May 01, 2017
ClearFlow Inc. has received the prestigious 2017 Global Frost & Sullivan Award for New Product Innovation. The...
Overlay Init